Velarion Records
Free. Unsubscribe any time.

2 associated locations — data as of November 17, 2026

Hemophilia treatment center · Downers Grove, IL

The Bleeding and Clotting Disorders Institute

Taking partNo

  • 0Registered locations
  • 2Associated locations
  • 0Contract pharmacies
  • 0With no end date
  • January 1, 2027In 340B since

The Bleeding and Clotting Disorders Institute among Illinois Hemophilia treatment center registrations

Illinois has 4 active Hemophilia treatment center registrations in the HRSA 340B register. HM60515 began participating on January 1, 2027; 3 of the Illinois registrations of its type began earlier. Downers Grove has 2 active registrations of every type.

Other 340B registrations in Downers Grove

Finances, as filed

These figures come from the hospital Medicare cost report, form CMS-2552-10, which is not filed under this registration type.

Get an email when this record changes

A daily email when The Bleeding and Clotting Disorders Institute changes.

Start a 30-day trial on this record

Start with a 30-day card trial — your card is required now and charged nothing until the trial ends, then $99/month continues automatically. Cancel anytime during the trial and pay nothing.

See a sample

Changes recorded

Nothing on this record has moved since it was first read here on November 9, 2026.

Register detail and identifiers

Participation, as filed

Participating
FALSE
Participation start date
January 1, 2027
Record last edited
November 8, 2026

Identifiers

340B ID
HM60515
Entity type as filed
HM
Grant number
H30MC24052
NPI
1134424633 (IL), 1528925666 (IL), 1639508567 (IL), 1962783431 (IL)

3825 Highland Avenue - Suite 2D, Downers Grove IL 60515

Associated locations

The Bleeding and Clotting Disorders Institute3825 Highland Avenue - Suite 2DDowners Grove IL 60515
The Bleeding and Clotting Disorders Institute Pharmacy427 W. Northmoor RdPeoria IL 61614

Source: HRSA 340B OPAIS Covered Entity Daily Report, file 340B_CoveredEntity_Daily_20261117_071011.xlsx, stamped November 17, 2026; first read here November 9, 2026. Method.